| EDUCATION |
| Specialty Residency in Critical Care, University of Iowa Hospitals and Clinics, Iowa City, IA, July 2006-June 2007 |
| Pharmacy Practice Residency, University of Iowa Hospitals and Clinics, Iowa City, IA, July 2005-June 2006 |
| Pharmacist, State of Iowa, June 2005 |
| Doctor of Pharmacy, University of Iowa, College of Pharmacy, Iowa City, IA, May 2005 |
| Professional
Experience |
| Clinical Pharmacy Specialist, VA Medical Center, Iowa City, IA, July 2007-present |
| Assistant Professor (Clinical), Division of Clinical and Administrative Pharmacy, University of Iowa College of Pharmacy, Iowa City, IA, July 2007-present |
| Organizational
Memberships |
| American College of Clinical Pharmacy, 2008-present |
| Society of Critical Care Medicine, 2007-present |
| American Society of Health-Systems Pharmacists 2005-present |
| American Pharmacists Association, 2002-present |
| Iowa Pharmacy Association, 2002-2005, 2007-present |
| Academy of Student Pharmacists, 2002-2005 |
| Select Scholarly
Activities |
| Cantrell MA, Bream-Rouwenhorst HR, Hemerson P, Magera JS. Silodosin for benign prostatic hypertrophy. Ann Pharmacother. [in press] |
| Bream-Rouwenhorst HR. Rookies: New Drugs for 2009. 4th Annual Cardiovascular Update: Fight, Fight, Fight for Iowa Heart Health. Iowa City, IA: 9 October 2009. |
| Bream-Rouwenhorst HR, Cantrell MA. Alvimopan for post-operative ileus. Am J Health Syst Pharm. 2009; 66(14):1267-77. |
| Bream-Rouwenhorst HR, Hobbs RA. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia (HIT). Pharmacotherapy. 2008; 28(11):1401-7 |
| Bream-Rouwenhorst HR, Hobbs RA. Heparin-dependent antibodies and thrombosis without heparin-induced thrombocytopenia (HIT). Pharmacotherapy. 2008; 28(11):__-__. [in press] |
Bream-Rouwenhorst HR, Hobbs RA. Pulmonary hypertension: an update. U.S. Pharmacist. 2008; 33(8):9-16. |
| Bream-Rouwenhorst HR, Hobbs RA, Horwitz PA. Thrombocytopenia in patients treated with heparin, combination antiplatelet therapy, and intra-aortic balloon pump counterpulsation. J Interv Cardiol. 2008; 21(4):350-6. Epub 3 Jun 2008. |
| Cantrell MA, Bream-Rouwenhorst HR, Steffensmeier A, Hemerson P, Rogers M, Stamper B. Intraoperative floppy iris syndrome and alpha-1 adrenegic receptor antagonists for benign prostatic hyperplasia. Ann Pharmacother. 2008; 42(4):558-63. |
| Bream-Rouwenhorst HR, Beltz EA, Ross MB, Moores KG. Recent developments in the management of acute respiratory distress syndrome in adults. Am J Health Syst Pharm. 2008; 65:29-36. |
| Bream-Rouwenhorst HR, Hobbs RA, Horwitz PA. Risk of thrombocytopenia and analysis of direct thrombin inhibitor use in patients treated with intra-aortic balloon pump counterpulsation. ASHP Midyear Clinical Meeting. 2006; 41(Dec). Abstract. |
| Bream-Rouwenhorst HR, Beltz EA, Doerschug K. Duration of Hypotension in Patients with Septic Shock Prior to Effective Antimicrobial Administration: a Quality Improvement Project. Midwest Pharmacy Residents' Conference. Omaha, NE; 30 April 2007. |
| Bream-Rouwenhorst HR, Hobbs RA, Horwitz PA. Risk of thrombocytopenia and analysis of direct thrombin inhibitor use in patients treated with intra-aortic balloon pump counterpulsation. Abstract 33. ASHP Midyear Clinical Meeting 2006. Anaheim, CA; 4 December 2006. |
| Bream-Rouwenhorst HR, Hobbs RA, Horwitz PA. Thrombocytopenia and analysis of direct thrombin inhibitor use in patients treated with intra-aortic balloon pump counterpulsation. Midwest Pharmacy Residents' Conference. Omaha, NE; 28 April 2006. |
| Bream-Rouwenhorst HR, Hobbs RA, Horwitz PA. Thrombocytopenia and analysis of direct thrombin inhibitor use in patients treated with intra-aortic balloon pump counterpulsation. University of Iowa, College of Pharmacy 7th Annual Research Achievement Symposium and Poster Session. Iowa City, IA; 26 April 2006. |
Bream-Rouwenhorst HR, Hobbs RA, Horwitz PA. Thrombocytopenia and direct thrombin inhibitor use in patients treated with intra-aortic balloon pump counterpulsation. UHC Pharmacy Council Meeting Poster Session. Las Vegas, NV; 3 December 2005. |
Bream-Rouwenhorst HR. CE Presentation on "Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA. 2006; 296:2947-53." Log in To Learn: an e-Journal Club for Pharmacists. Collaborative Education Institute. 12 March 2008. |
| Bream-Rouwenhorst HR. Novel Anticoagulants for Acute Coronary Syndromes. 2nd Annual Cardiovascular Update: Fight, Fight, Fight for Iowa Heart Health. Iowa City, Iowa: 28 September 2007. |
| Bream-Rouwenhorst HR. Use of Nonsteroidal Anti-inflammatory Drugs in the Cardiac Population. 2nd Annual Cardiovascular Update: Fight, Fight, Fight for Iowa Heart Health. Iowa City, Iowa: 28 September 2007. |
| Bream-Rouwenhorst HR. MRSA Update 2007: Therapeutic Alternatives. Johnson County Pharmacists' Association Meeting. Iowa City, IA; 15 May 2007. |
Heather R. Bream-Rouwenhorst, Pharm.D., BCPS 